ExcelFin Acquisition Corp.

Status: Closed Deal

U=S+W/2 W=S@11.50

IPO Proceeds, $M	$230.00M
IPO Date	Oct 21, 2021
CEO	Joe Ragan
Left Lead	UBS
IPO Cash in Trust	102.0%
SPAC Tenor	18 + 6 + 6 + 3 + 5
IPO Sector	Financial U.S. domiciled Financial Technology
IPO Geography	US/Canada
Target Company	Baird Medical
Deal Announced	Jun 26, 2023
Deal Size, $M	$279.00M
Deal Sector	Healthcare
Deal Geography	Asia
SEC Filings	www.sec.gov
Approval Vote	Sep 26, 2024
Amendment Vote	Jul 24, 2024
Closing Date	Oct 1, 2024

Formerly XFIN BDMD BDMDW

Price	$7.75
Last closing price	$5.42
H/L, today	$5.05 / $11.86
Volume, today	18,603,909
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$0.13
Last closing price	$0.08
High/low price, today	$0.07 / $0.15
Volume, today	344,928
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

No credit card required

Structure and cap table
8 directors & officers
48 filings and events
3 underwriters
2 deal advisors
2 legal advisors

Structure

Sign in to view structure, cap table, and calendar of events.

Team

Name	Age	Title
Jennifer Hill	55	Chairman of the Board
Joe Ragan	61	CEO and Director
Brian Sun	48	COO
Joe Ragan	59	Chief Financial Officer
Brian Sun	45	Executive Vice President
Gary Meltzer	57	Director
Neil Wolfson	56	Director
Goh Lin Piao	56	Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors

Underwriters
UBS	BR	15,000,000	units
EXOS Securities		4,000,000
KeyBanc Capital Markets		1,000,000
		20,000,000	units
	Up-Front UW fee	2.00	%
	Deferred UW fee	3.50	%

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings


Oct 5, 2021	Initial S-1
Oct 15, 2021	Amended S-1 Sign In to view filing content.
Oct 20, 2021	PR announcing pricing of $200mm IPO Sign In to view filing content.
Oct 22, 2021	424B4 IPO Prospectus
Oct 29, 2021	8-K announcing full over-allotment exercise Sign In to view filing content.
Dec 10, 2021	8-K announcing separate trading of common stock and warrants Sign In to view filing content.
Mar 9, 2023	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
Mar 24, 2023	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Mar 24, 2023	8-K announcing non-redemption agreement Sign In to view filing content.
Apr 6, 2023	8-K announcing additional non-redemption agreement Sign In to view filing content.
Apr 19, 2023	8-K with extension meeting results Sign In to view filing content.
Apr 20, 2023	8-K announcing change in Directors Sign In to view filing content.
Jun 26, 2023	8-K announcing business combination with Baird Medical Sign In to view filing content.
Aug 21, 2023	F-4 registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Sep 6, 2023	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
Sep 26, 2023	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Oct 17, 2023	DEFA14A announcing adjournment of charter extension meeting Sign In to view filing content.
Oct 26, 2023	8-K with extension meeting results Sign In to view filing content.
Nov 22, 2023	425 with update on intended merger target - Baird Medical Sign In to view filing content.
Nov 28, 2023	F-4/A Amendment #1 to registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Dec 12, 2023	8-K with updated investor presentation Sign In to view filing content.
Jan 19, 2024	F-4/A Amendment #2 to registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Jan 26, 2024	8-K with updated investor presentation Sign In to view filing content.
Mar 11, 2024	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
Mar 12, 2024	PR with update on intended merger target - Baird Medical Sign In to view filing content.
Mar 12, 2024	8-K with amendment #1 to Baird Medical merger agreement Sign In to view filing content.
Mar 18, 2024	F-4/A Amendment #3 to registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Mar 18, 2024	8-K with updated investor presentation Sign In to view filing content.
Mar 22, 2024	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Apr 11, 2024	DEFA14A with updated extension meeting details Sign In to view filing content.
Apr 22, 2024	DEFA14A announcing postponement of charter extension meeting, increase in proposed contribution, and preliminary redemption statistics Sign In to view filing content.
Apr 25, 2024	8-K with extension meeting results Sign In to view filing content.
May 16, 2024	8-K with amendment #2 to Baird Medical merger agreement Sign In to view filing content.
Jun 12, 2024	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
Jun 20, 2024	8-K with amendment #3 to Baird Medical merger agreement Sign In to view filing content.
Jun 20, 2024	F-4/A Amendment #4 to registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Jun 25, 2024	DEF14A Definitive proxy for charter extension meeting Sign In to view filing content.
Jun 27, 2024	8-K with updated investor presentation Sign In to view filing content.
Jul 17, 2024	DEFA14A announcing postponement of charter extension meeting Sign In to view filing content.
Jul 19, 2024	F-4/A Amendment #5 to registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Jul 24, 2024	8-K with extension meeting results Sign In to view filing content.
Aug 12, 2024	F-4/A Amendment #6 to registration statement containing preliminary proxy for Baird Medical business combination
Aug 23, 2024	8-K with amendment #4 to Baird Medical merger agreement Sign In to view filing content.
Aug 26, 2024	F-4/A Amendment #7 to registration statement containing preliminary proxy for Baird Medical business combination Sign In to view filing content.
Sep 5, 2024	DEFM14A Definitive Proxy for Baird Medical business combination Sign In to view filing content.
Sep 26, 2024	8-K with Baird Medical meeting results Sign In to view filing content.
Sep 27, 2024	8-K with update on closing timeline and expected redemption price Sign In to view filing content.
Oct 1, 2024	CA Corporate Action Alert announcing closing of Baird Medical business combination Sign In to view filing content.